Cross-talk between coagulation and inflammation in COPD. The role of Factor XIII.

E. Bazzan (Padova (PD), Italy), C. Radu (Padova (PD), Italy), M. Tinè (Padova (PD), Italy), U. Semenzato (Padova (PD), Italy), S. Baraldo (Padova (PD), Italy), G. Turato (Padova (PD), Italy), P. Simioni (Padova (PD), Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova (PD), Italy)

Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Bazzan (Padova (PD), Italy), C. Radu (Padova (PD), Italy), M. Tinè (Padova (PD), Italy), U. Semenzato (Padova (PD), Italy), S. Baraldo (Padova (PD), Italy), G. Turato (Padova (PD), Italy), P. Simioni (Padova (PD), Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova (PD), Italy). Cross-talk between coagulation and inflammation in COPD. The role of Factor XIII.. 2299

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Coagulation factor XII regulates inflammatory responses in human lungs
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling
Source: Eur Respir Rev 2008; 17: 130-137
Year: 2008



Recruitment of Dendritic Cells by Factor XIII (FXIII) facilitates the immune response in COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020

The protease activated receptor (PAR)-2/tissue factor/coagulation factor VIIa axis in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation
Source: Eur Respir J 2007; 30: 423-428
Year: 2007



Coagulation in lung fibrosis: multiple pathways leading to fibroblast activation
Source: Annual Congress 2012 - PG11 Pulmonary fibrosis
Year: 2012

Role of coagulation cascade proteases and lung repair and fibrosis
Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease
Year: 2003

Role of coagulation cascade proteases in lung repair and fibrosis
Source: Eur Respir J 2003; 22: 33S-35S
Year: 2003


Hypercoagulability in patients with stable COPD assessed by coagulation factor levels
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels
Source: ERS Lung Science Conference 2021
Year: 2021

Hepatocyte growth factor – a link between neutrophilic inflammation and BOS?
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006

Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006

Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006



Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Role of vascular endotelial growth factor polymorphisms in interstitial lung disease
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019


LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010


Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012

Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002